MIMEDX director granted 50,913 restricted shares
HAWKINS WILLIAM A reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HAWKINS WILLIAM A reported acquisition or exercise transactions in this Form 4 filing.
MIMEDX GROUP, INC. director William A. Hawkins received an annual restricted stock grant of 50,913 shares of common stock at $3.64 per share. This grant is compensation for his service as a non-employee director and is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. Following this grant, Hawkins directly holds 254,931 shares of MIMEDX common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,913 | $3.64 | $185K |
Footnotes (1)
- F1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Key Figures
Key Terms
restricted stock financial
Rule 16b-3 regulatory
non-employee directors financial
vests financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MIMEDX (MDXG) director William A. Hawkins report?
Is the William A. Hawkins Form 4 transaction for MDXG a stock purchase or a grant?
What are the vesting terms of the MDXG restricted stock granted to William A. Hawkins?
Why is the MIMEDX (MDXG) stock grant to William A. Hawkins exempt under Rule 16b-3?
AI-generated analysis. How Rhea-AI works. Not financial advice.